← All medicines

Cancer medicines

Quizartinib

Independent educational summary · Sources checked November 20, 2026

Used with other chemotherapy for selected acute myeloid leukemia.

Profile scope: Quizartinib. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Digestive upset, mouth sores, reduced appetite, or sleep disturbance may occur.

Serious risks and warning signs

QT-related heart-rhythm disturbance can cause sudden death. Stop quizartinib and call the prescriber immediately for fast or irregular heartbeat, fainting, loss of consciousness or seizures; get emergency medical help for severe symptoms. Interactions and low potassium or magnesium can increase risk. ECG and laboratory monitoring are required, and access is through a restricted safety program.

A question for your healthcare team

Which interaction checks, ECGs, and electrolyte tests are required, and what is my emergency plan for fainting or palpitations?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.